PD-L1 anticorps (AA 192-241)
Aperçu rapide pour PD-L1 anticorps (AA 192-241) (ABIN799508)
Antigène
Voir toutes PD-L1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 192-241
-
Specificité
- Human CD274
-
Homologie
- Percent identity by BLAST analysis: Human (100%) Pig (84%).
-
Purification
- Immunoaffinity purified
-
Immunogène
-
Synthetic peptide located between aa192-241 of human CD274 (Q9NZQ7, NP_054862). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Marmoset (100%), Gibbon, Monkey (92%), Pig (84%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstitute with 50 μL sterile ddH2O.
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Conseil sur la manipulation
- Avoid repeat freeze-thaw cycles.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than one week): +4°C. Avoid repeat freeze-thaw cycles.
-
-
- PD-L1 (CD274 (PD-L1))
-
Autre désignation
- B7-H1 / PD-L1 / CD274
-
Sujet
-
Name/Gene ID: CD274
Synonyms: CD274, B7-H, B7 homolog 1, B7-H1, B7H1, CD274 Molecule, CD274 antigen, PDCD1 ligand 1, PDL1, PD-L1, PDCD1L1, PDCD1LG1, Programmed death ligand 1 -
ID gène
- 29126
-
NCBI Accession
- NP_054862
-
UniProt
- Q9NZQ7
-
Pathways
- Cancer Immune Checkpoints
Antigène
-